Drug Side Effects
Search
GASTROINTESTINAL NEUROENDOCRINE CARCINOMA
GASTROINTESTINAL NEUROENDOCRINE CARCINOMA
was reported 29 times
GASTROINTESTINAL NEUROENDOCRINE CARCINOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Glinide [EPC]
1
0.0001
1
Integrin Receptor Antagonist [EPC]
5
0.0001
2
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
1
0.0000
3
Topoisomerase Inhibitor [EPC]
2
0.0000
4
Janus Kinase Inhibitor [EPC]
2
0.0000
5
Vascular Endothelial Growth Factor Inhibitor [EPC]
2
0.0000
6
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
0.0000
7
Aminosalicylate [EPC]
1
0.0000
8
Angiotensin Converting Enzyme Inhibitor [EPC]
1
0.0000
9
Platinum-based Drug [EPC]
2
0.0000
10
Leukocyte Growth Factor [EPC]
1
0.0000
11
GLP-1 Receptor Agonist [EPC]
3
0.0000
12
Microtubule Inhibitor [EPC]
1
0.0000
13
Interferon beta [EPC]
1
0.0000
14
Proton Pump Inhibitor [EPC]
3
0.0000
15
Alkylating Drug [EPC]
1
0.0000
16
Corticosteroid [EPC]
5
0.0000
17
Factor Xa Inhibitor [EPC]
1
0.0000
18
Kinase Inhibitor [EPC]
2
0.0000
19
Vitamin D [EPC]
1
0.0000
20
Vitamin B12 [EPC]
1
0.0000
21
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
22
Vitamin C [EPC]
1
0.0000
23
Insulin Analog [EPC]
1
0.0000
24
Thalidomide Analog [EPC]
1
0.0000
25
Platelet Aggregation Inhibitor [EPC]
1
0.0000
26
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000